Related Experiment Video
Updated: Jun 12, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
The evaluation and management of insomnia
1Department of Psychiatry and Human Behavior, Jefferson Sleep Disorders Center, Thomas Jefferson University, 211 South Ninth Street, Suite 500, Philadelphia, PA 19107, USA. Karl.Doghramji@jefferson.edu
Insomnia, a common sleep disorder, significantly impacts daily life due to heightened arousal. Comprehensive evaluation is key to managing insomnia by identifying and treating comorbid conditions.
Area of Science:
- Neuroscience
- Sleep Medicine
- Psychiatry
Background:
- Insomnia is a prevalent disorder affecting daily function.
- Its pathophysiology involves heightened neurophysiologic and psychological arousal.
- Insomnia frequently coexists with medical and psychiatric conditions.
Purpose of the Study:
- To outline the management of insomnia.
- To emphasize the importance of identifying comorbid disorders.
- To highlight available treatment options for primary insomnia.
Main Methods:
- Comprehensive evaluation to identify comorbid disorders.
- Tailoring treatments to underlying conditions.
- Utilizing cognitive/behavioral and pharmacologic techniques.
Main Results:
- Identification of comorbid disorders is the primary management step.
- Specific treatments can be directed at identified underlying conditions.
- Effective treatments exist for primary insomnia.
Conclusions:
- Effective management of insomnia requires a comprehensive approach.
- Addressing comorbid conditions is crucial for successful treatment.
- Both cognitive/behavioral and pharmacologic therapies are effective for primary insomnia.
More Related Videos
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
CNS Depressants: Barbiturates and Benzodiazepines
Blind Procedures